Maze Therapeutics, Inc. (MAZE)
Nasdaq: MAZE · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2024
Who runs Maze Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Coloma Jason V
Chief Executive Officer. First filing Jan 2025, latest Nov 4, 2026, 10 filings in all.
Officers reporting now
6
of 18 people with a filing in the last fifteen months
Directors reporting now
12
21 people on the record since 2025
Officerssales are open-market, Nov 4, 2025 to Nov 4, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Coloma Jason V | Chief Executive Officer | Jan 2025 | Nov 4, 2026 | 29 · $7.2M |
| Dandekar Atul | CSBO | Jan 2025 | Oct 30, 2026 | 22 · $5.5M |
| Bernstein Harold | President, R&D & CMO | Jan 2025 | Oct 2, 2026 | 30 · $9.5M |
| Courtney Phillips | GC and Corp. Secretary | Jan 2025 | Sep 4, 2026 | 4 · $100,000 |
| Bachrodt Amy | SVP, Finance | Jan 2025 | Apr 2, 2026 | 13 · $1.6M |
| Tahir Misbah | Chief Financial Officer | Sep 2025 | Mar 3, 2026 | none |
Directorssales are open-market, Nov 4, 2025 to Nov 4, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Johnson Paula A | director | Aug 2026 | Aug 17, 2026 | none |
| Kornowski Sophie | director | Aug 2026 | Aug 17, 2026 | none |
| Andrews Nancy C | director | Jan 2025 | Jun 10, 2026 | none |
| Homcy Charles J | director | Jan 2025 | Jun 10, 2026 | none |
| Hoppenot Herve | director | Oct 2025 | Jun 10, 2026 | none |
| Lim Jonathan E | director | Jan 2025 | Jun 10, 2026 | none |
| Scheller Richard H | director | Jan 2025 | Jun 10, 2026 | none |
| Spiegelman Daniel K | director | Jan 2025 | Jun 10, 2026 | none |
| Kumar Neil | director | Mar 2026 | Mar 31, 2026 | none |
| Sohn Catherine A. | director | Jan 2025 | Jan 8, 2026 | 2 · $1.1M |
| Exter Neil | director | Jan 2025 | Sep 24, 2025 | none |
| Kathiresan Sekar | director | Jan 2025 | Sep 24, 2025 | none |
Owners of more than 10% of a classsales are open-market, Nov 4, 2025 to Nov 4, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Third Rock Ventures Gp IV, L.P. | 10% owner | Jan 2025 | Nov 5, 2025 | none |
| Third Rock Ventures Gp V, LP | 10% owner | Jan 2025 | Nov 5, 2025 | none |
| Third Rock Ventures IV, L.P. | 10% owner | Jan 2025 | Nov 5, 2025 | none |
| Third Rock Ventures V, L.P. | 10% owner | Jan 2025 | Nov 5, 2025 | none |
| Trv Gp IV, LLC | 10% owner | Jan 2025 | Nov 5, 2025 | none |
| Trv Gp V, LLC | 10% owner | Jan 2025 | Nov 5, 2025 | none |
Earlier names on the record12, newest filing first
Brush James · director · last filing Jan 2025Colowick Alan · director · last filing Jan 2025Tong Jeffrey K · director · last filing Jan 2025Arch Venture Fund X Overage, L.P. · 10% owner · last filing Jan 2025Arch Venture Fund X, L.P. · 10% owner · last filing Jan 2025Arch Venture Partners X Overage, L.P. · 10% owner · last filing Jan 2025Arch Venture Partners X, L.P. · 10% owner · last filing Jan 2025Arch Venture Partners X, LLC · 10% owner · last filing Jan 2025Burow Kristina · 10% owner · last filing Jan 2025Crandell Keith · 10% owner · last filing Jan 2025Gillis Steven · 10% owner · last filing Jan 2025Nelsen Robert · 10% owner · last filing Jan 2025
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.